Talk:Tomáš Cihlář

This article is rated C-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Mid‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Mid	This article has been rated as Mid-importance on the project's importance scale.

Viruses Mid‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus
Mid	This article has been rated as Mid-importance on the project's importance scale.

COVID-19 Mid‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine: Society Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Society and Medicine task force (assessed as Low-importance).

Biography: Science and Academia

	Biography portal This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography
	This article is supported by the science and academia work group.
	This article has been automatically rated by a bot or other tool because one or more other projects use this class. Please ensure the assessment is correct before removing the `\|auto=` parameter.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tomáš Cihlář.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Did you know nomination

The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.

The result was: rejected by Yoninah (talk) 11:15, 21 June 2020 (UTC)[reply]
Issues raised in review unaddressed

(

Comment or view
Article history

)

... that as a student, Czech American virologist Tomáš Cihlář, known today for developing hopeful anti-Covid-19 drug remdesivir, assisted Antonín Holý in developing tenofovir disoproxil, the primary drug used in the fight against HIV?^[1]^[2]
- ALT1:... that Czech American virologist Tomáš Cihlář is credited with developing both tenofovir disoproxil to fight HIV and remdesivir to fight Covid-19?^[1]^[2]

Reviewed: Template:Did you know nominations
Created/expanded by Swmmng (talk). Self-nominated at 13:12, 23 April 2020 (UTC).[reply]

@Swmmng: New and long enough, Earwig detects no copyvios. I'd like to see more specifics and better sourcing about Cihlář's involvement in developing remdesivir; these are generally large team efforts and simply saying he developed it himself isn't sufficient detail. Was he a laboratory scientist, a research group head, or was it in his executive position at Gilead? John P. Sadowski (NIOSH) (talk) 23:39, 21 May 2020 (UTC)[reply]

Nominator has not edited since June 9. But I am leaving a note on his talk page giving him a week to respond to this review or else the nomination will be closed as unsuccessful. Yoninah (talk) 20:06, 15 June 2020 (UTC)[reply]

The nominator hasn't edited since the 9th and has not responded to the comments left in the nomination or addressed the above issues; their last edit to the article (and their most recent edit on Wikipedia) did not give the necessary specifics requested above. Marking for closure as unsuccessful. Narutolovehinata5 ^tccsdnew 02:49, 21 June 2020 (UTC)[reply]

References

^ ^a ^b Anon., "Remdesivir Cleared For Use On Covid-19 Patients in Four Czech Hospitals", Prague Morning, April 29, 2020.
^ ^a ^b Saiver, F., "Je Remdesivir lékem na covid-19? O objevu týmu Tomáše Cihláře má být jasno už do konce dubna", Forbes, April 8, 2020.

[PM-1] Anon., "Remdesivir Cleared For Use On Covid-19 Patients in Four Czech Hospitals", Prague Morning, April 29, 2020.

[F-2] Saiver, F., "Je Remdesivir lékem na covid-19? O objevu týmu Tomáše Cihláře má být jasno už do konce dubna", Forbes, April 8, 2020.

[1]

[2]